Test Price
2,800 AED✅ Home Collection Available
ST14 Gene Genetic Test for Autosomal Recessive Congenital Ichthyosis Type 11 (ARCI11) in UAE – 2800 AED
Executive Summary & Core Metrics
Executive Summary: The ST14 Gene NGS Test delivers 99.9% diagnostic sensitivity for autosomal recessive congenital ichthyosis type 11 (ARCI11), processed in our ISO 9001:2015 certified laboratory. Benefit from VIP mobile phlebotomy and temperature-controlled cold-chain home collection across all seven UAE emirates, available daily from 8 AM to 11 PM. Post-test clinical guidance is provided with every report. For direct billing verification, share your insurance card via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This targeted Next-Generation Sequencing (NGS) assay analyses all coding exons and splice junctions of the ST14 gene, the definitive marker for autosomal recessive congenital ichthyosis type 11 (ARCI11). It replaces older single-gene Sanger workflows with a highly multiplexed, LC‑MS/MS‑validated sequencing chemistry that ensures complete exon coverage and variant detection even in challenging GC‑rich regions.
| Feature | Our Test (ST14 NGS) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Diagnostic Precision | 99.9% analytical sensitivity, full gene coverage | ~98% per amplicon; may miss deep intronic variants |
| Methodology | NGS with Illumina® platform, bioinformatic variant calling | Sanger sequencing, limited to defined regions |
| Turnaround Time | 3 to 4 weeks | 6 to 8 weeks |
| UAE Compliance | DHA/MOHAP registered, ISO 9001:2015, PDPL-compliant | Variable; rarely ISO certified |
Physician Insight & Safety Protocols
“The ST14 NGS test provides a cornerstone for the precise molecular diagnosis of ARCI11. While results are highly accurate, they must always be correlated with clinical findings and family history. I encourage every patient to undergo a structured genetic counselling session before and after the test to interpret the implications fully.”
— Ms. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication Continuity
Do not discontinue or adjust any prescribed topical or systemic medication (retinoids, emollients, keratolytics) without explicit instruction from your consultant dermatologist or paediatrician.
Exclusion Criteria & Red Flags
- Acute febrile illness or active systemic infection at time of sample collection.
- Recent whole blood transfusion (< 4 weeks) or bone marrow transplant.
- Lack of informed consent or refusal of mandatory pre‑test genetic counselling session.
- If the patient exhibits severe erythema, blistering, or signs of neonatal sepsis, seek immediate emergency care—do not delay for genetic testing.
- Failure to thrive, electrolyte imbalances, or respiratory distress in a newborn requires urgent paediatric assessment.
Patient FAQ & Clinical Guidance
1. What exactly does the ST14 NGS test detect, and how accurate is it?
The ST14 NGS identifies single nucleotide variants, small insertions/deletions, and copy number changes in all coding exons of the ST14 gene with 99.9% analytical sensitivity. It is the most comprehensive molecular assay for ARCI11, validated on hundreds of clinical samples in our DHA‑licensed facility. Results are interpreted according to ACMG/AMP guidelines, and every report includes a clinician‑friendly pathogenicity classification.
2. Is home collection available across all UAE emirates and how should I prepare?
Our ISO‑certified cold‑chain mobile phlebotomy team reaches Abu Dhabi, Dubai, Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah, and Fujairah daily from 8 AM to 11 PM. No fasting is required; simply continue your regular medication and skincare routine. A trained phlebotomist collects a single 3 mL EDTA whole blood sample or a dried blood spot on an FTA card, ensuring sample stability during transport.
3. How long until I receive my report and what support do you offer afterwards?
The final signed report is delivered within 3 to 4 weeks via encrypted email and patient portal. Once results are ready, you may schedule a complimentary 15‑minute telephonic clinical guidance session with our genetics team to interpret the findings, understand recurrence risks, and plan any necessary dermatological or paediatric follow‑up.
UAE Regulatory & Data Privacy Adherence
Data Protection: Your genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All samples and results are handled with strict confidentiality and encrypted storage. Clinical safety and consent procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | ST14 Gene NGS Test for Autosomal Recessive Congenital Ichthyosis Type 11 (ARCI11) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or Dried Blood Spot (FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) on Illumina® platform |
| ICD-10-CM Code | Q80.8 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians